What are the different characteristics of homologous recombination deficiency (HRD) tests?

March 12, 2024

In this video, Dr. Nicola Normanno (National Cancer Institute Pascale Foundation, Naples Italy) explains how the institute became a reference center for NGS and precision oncology in southern Italy. He describes the research on homologous recombination deficiency (HRD) and which assay characteristics labs should consider when internalizing HRD testing for ovarian cancer. #HRD #CGP #precisionmedicine #oncology #diagnostics #BRCA #cancer #illumina Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: facebook.com/illuminainc LinkedIn: linkedin.com/company/illumina Instagram: instagram.com/illuminainc Twitter: twitter.com/illumina
Share this article on